{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:40:25Z","timestamp":1790548825943,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Gerontology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.exger.2019.02.019","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T22:41:12Z","timestamp":1551480072000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The relationship between polypharmacy and trajectories of cognitive decline in people with dementia: A large representative cohort study"],"prefix":"10.1016","volume":"120","author":[{"given":"Pinar","family":"Soysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayan","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet Turan","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7506-8646","authenticated-orcid":false,"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-9897","authenticated-orcid":false,"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-289X","authenticated-orcid":false,"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9816-1686","authenticated-orcid":false,"given":"Christoph","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exger.2019.02.019_bb0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178562","article-title":"Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort","volume":"12","author":"Baker","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.exger.2019.02.019_bb0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/gps.4507","article-title":"Anticholinergic effect on cognition (AEC) of drugs commonly used in older people","volume":"32","author":"Bishara","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/gps.4507","article-title":"Anticholinergic effect on cognition (AEC) of drugs commonly used in older people","volume":"32","author":"Bishara","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0020","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JAD-180382","article-title":"The influence of polypharmacy on the initiation of anti-dementia therapy in Germany","volume":"64","author":"Bohlken","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.exger.2019.02.019_bb0025","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1192\/bjp.174.5.424","article-title":"Health of the Nation Outcome Scales for elderly people (HoNOS 65+)","volume":"174","author":"Burns","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jamda.2012.05.015","article-title":"Underrecognition and undertreatment of dementia in Italian nursing homes","volume":"13","author":"Cherubini","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1","key":"10.1016\/j.exger.2019.02.019_bb0035","first-page":"33","article-title":"Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data","volume":"46","author":"Clague","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.exger.2019.02.019_bb0040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1014348124664","article-title":"GATE, a general architecture for text engineering","volume":"36","author":"Cunningham","year":"2002","journal-title":"Comput. Hum."},{"key":"10.1016\/j.exger.2019.02.019_bb0045","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0b013e3181b59bf3","article-title":"Treatment of vascular risk factors is associated with slower decline in Alzheimer disease","volume":"73","author":"Deschaintre","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.exger.2019.02.019_bb0050","doi-asserted-by":"crossref","first-page":"M173","DOI":"10.1093\/gerona\/57.3.M173","article-title":"Prevalence and impact of medical comorbidity in Alzheimer's disease","volume":"57","author":"Doraiswamy","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2019.02.019_bb0055","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/jgs.14092","article-title":"Association between accelerated multimorbidity and age-related cognitive decline in older baltimore longitudinal study of aging participants without dementia","volume":"64","author":"Fabbri","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.exger.2019.02.019_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjpo.bp.116.004184","article-title":"Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease","volume":"3","author":"Fazal","year":"2017","journal-title":"BJPsych Open"},{"key":"10.1016\/j.exger.2019.02.019_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.exger.2019.02.019_bb0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ageing\/afu096","article-title":"Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review","volume":"43","author":"Fox","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.exger.2019.02.019_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/gps.4965","article-title":"Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative review","author":"Isik","year":"2018","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4080","article-title":"Association of concomitant use of cholinesterase inhibitors or memantine with cognitive decline in alzheimer clinical trials: a meta-analysis","volume":"1","author":"Kennedy","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.exger.2019.02.019_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000017112","article-title":"Impact of the type and severity of dementia on hospitalization and survival of the elderly. The SAGE Study Group","volume":"10","author":"Landi","year":"1999","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.exger.2019.02.019_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/WAD.0b013e31819d6ec9","article-title":"Polypharmacy and potentially inappropriate medication use among community-dwelling elders with dementia","volume":"24","author":"Lau","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.exger.2019.02.019_bb0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1517\/14740338.2013.827660","article-title":"Clinical consequences of polypharmacy in elderly","volume":"13","author":"Maher","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.exger.2019.02.019_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084014","article-title":"The influence of multimorbidity on clinical progression of dementia in a population-based cohort","volume":"8","author":"Melis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2019.02.019_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10433-012-0234-8","article-title":"Using the Folstein Mini Mental State Exam (MMSE) to explore methodological issues in cognitive aging research","volume":"9","author":"Monroe","year":"2012","journal-title":"Eur. J. Aging"},{"key":"10.1016\/j.exger.2019.02.019_bb0110","first-page":"1","article-title":"Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis","author":"Mueller","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.exger.2019.02.019_bb0115","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.exger.2018.02.011","article-title":"Polypharmacy in people with dementia: Associations with adverse health outcomes","volume":"106","author":"Mueller","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.exger.2019.02.019_bb5000","article-title":"Dementia: Supporting People with Dementia and Their Carers in Health and Social Care","volume":"42","author":"National Institute for Health and Clinical Excellence\/Social Care Institute for Excellence","year":"2006"},{"key":"10.1016\/j.exger.2019.02.019_bb0120","series-title":"The English Indices of Deprivation 2007","author":"Noble","year":"2007"},{"key":"10.1016\/j.exger.2019.02.019_bb0125","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the SHELTER study","volume":"67","author":"Onder","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.exger.2019.02.019_bb0130","article-title":"The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2019.02.019_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109484","article-title":"Factors associated with response to acetylcholinesterase inhibition in dementia: a cohort study from a secondary mental health care case register in london","volume":"9","author":"Perera","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exger.2019.02.019_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008721","article-title":"Cohort profile of the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Case Register: current status and recent enhancement of an Electronic Mental Health Record-derived data resource","volume":"6","author":"Perera","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.exger.2019.02.019_bb0145","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/jgs.15317","article-title":"Associations between polypharmacy and cognitive and physical capability: a British birth cohort study","volume":"66","author":"Rawle","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.exger.2019.02.019_bb0150","first-page":"507","article-title":"Generalized additive models for location, scale and shape","author":"Rigby","year":"2005","journal-title":"Appl. Stat."},{"key":"10.1016\/j.exger.2019.02.019_bb0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1440-1819.2007.01729.x","article-title":"Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study","volume":"61","author":"Rocca","year":"2007","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.exger.2019.02.019_bb0160","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/gps.3769","article-title":"The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease","volume":"27","author":"Rosenberg","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-244X-9-51","article-title":"The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data","volume":"9","author":"Stewart","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0170","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S1041610217001090","article-title":"Use of psychotropic medications in relation to neuropsychiatric symptoms, cognition and functional performance in Alzheimer's disease over a three-year period: Kuopio ALSOVA study","volume":"29","author":"Tormalehto","year":"2017","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.exger.2019.02.019_bb0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12916-014-0160-z","article-title":"Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review","volume":"12","author":"Valenti","year":"2014","journal-title":"BMC Med."},{"key":"10.1016\/j.exger.2019.02.019_bb0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jalz.2012.09.009","article-title":"Polypharmacy in nursing home residents with severe cognitive impairment: results from the SHELTER Study","volume":"9","author":"Vetrano","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.exger.2019.02.019_bb0185","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jamda.2018.04.008","article-title":"Association of polypharmacy with 1-year trajectories of cognitive and physical function in nursing home residents: results from a multicenter European study","volume":"19","author":"Vetrano","year":"2018","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.exger.2019.02.019_bb0190","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD","volume":"168","author":"Vigen","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.exger.2019.02.019_bb0195","series-title":"International Statistical Classifications of Diseases and Related Health Problems. 10th Revision Vol 2 Instruction Manual","author":"World Health Organisation","year":"2010"}],"container-title":["Experimental Gerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519300105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0531556519300105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T16:57:03Z","timestamp":1554829023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0531556519300105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":40,"alternative-id":["S0531556519300105"],"URL":"https:\/\/doi.org\/10.1016\/j.exger.2019.02.019","relation":{},"ISSN":["0531-5565"],"issn-type":[{"value":"0531-5565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between polypharmacy and trajectories of cognitive decline in people with dementia: A large representative cohort study","name":"articletitle","label":"Article Title"},{"value":"Experimental Gerontology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exger.2019.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}